Published January 2020 | Version v1
Journal article Metadata-only

Durvalumab after radiochemotherapy for locally advanced unresectable NSCLC. A breakthrough

Creators

  • 1. Department of Radiation Oncology, Competence Center Palliative Care, University Hospital Zurich (USZ) (Switzerland)

Description

no abstract available

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00066-019-01545-3

Additional details

Additional titles

Original title (German)
Durvalumab nach Radiochemotherapie beim lokal fortgeschrittenen inoperablen NSCLC. Ein Sprung nach vorn

Identifiers

DOI
10.1007/s00066-019-01545-3;

Publishing Information

Journal Title
Strahlentherapie und Onkologie
Journal Volume
196
Journal Issue
1
Journal Page Range
p. 95-97
ISSN
0179-7158
CODEN
STONE4

INIS

Country of Publication
Germany
Country of Input or Organization
Germany
INIS RN
51039272
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
No Abstract
Descriptors DEI
BRONCHI; CARCINOMAS; CHEMOTHERAPY; COMBINED THERAPY; GY RANGE 10-100; LUNGS; MONOCLONAL ANTIBODIES; RADIOIMMUNOTHERAPY; SURVIVAL TIME
Descriptors DEC
ABSORBED DOSE RANGE; ANTIBODIES; BODY; DISEASES; GY RANGE; IMMUNOTHERAPY; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIATION DOSE RANGES; RADIOLOGY; RADIOTHERAPY; RESPIRATORY SYSTEM; THERAPY